
CYTK Technical Analysis Summary (NASDAQ)
Analyze CYTK on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerCYTK Technical Analysis Summary (NASDAQ)
Cytokinetics, Incorporated (NASDAQ: CYTK) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Cytokinetics, Incorporated on the NASDAQ is awaiting a decisive move. This mix signals that Cytokinetics, Incorporated is trading in a balanced range with no clear breakout yet.
RSI (14): 48.21
Stochastic %K: 55.03
Williams %R: -45.60
Rate of Change (ROC): 1.20
Takeaway:Cytokinetics, Incorporated shows neutral momentum, with indicators pointing to indecision.
MACD: -0.96
ADX: 10.74
ATR (14): 2.56
CCI (14): 17.37
Takeaway:Cytokinetics, Incorporated shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Cytokinetics, Incorporated trades closer to support, showing weaker momentum within bands.
Takeaway:Cytokinetics, Incorporated trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:CYTK shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
No significant bearish signals detected.
Overall Recommendation:Technical indicators for Cytokinetics, Incorporated are mixed, suggesting a Hold or wait-and-see approach.